Inhibrx Biosciences, Inc. (INBX)
127.95
-0.84
(-0.65%)
USD |
NASDAQ |
May 04, 16:00
126.70
-1.25
(-0.98%)
Pre-Market: 20:00
Inhibrx Biosciences EPS Diluted (Quarterly) : -2.114 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | -1.715 |
| Boston Scientific Corp. | 0.897 |
| Intuitive Surgical, Inc. | 2.283 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| Inovio Pharmaceuticals, Inc. | 0.0546 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.83M |
| Total Expenses (Quarterly) | 32.83M |
| Enterprise Value | 1.852B |
| Earnings Yield | -7.07% |
| Normalized Earnings Yield | -7.068 |